Lördag 12 Juli | 15:21:19 Europe / Stockholm

Prenumeration

2025-07-08 09:12:00

Redeye comments on Carasent’s preliminary Q2 figures, the revised 2025 targets, and the new mid-term targets.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/